Get in touch

Submit

Thank you

Patent protection

We know from experience that innovation is a dynamic process that can generate a diverse range of creative outputs. Some of these are best protected with patents that cover the technical elements of innovation and invention.

 

We take pride in the quality of our patent drafting - our wealth of direct clients means that we draft often and that we draft well. Building patent portfolios that support growth, underpin core technology platforms and provide a competitive advantage in the global marketplace is an essential part of the value we offer. We know how to catch the spirit of innovation and to transform it into an asset. We make the complex patent process accessible, giving you clear and practical guidance on how to get the best protection for your needs.

 

Patent consulting

Our patent consulting services can help your company navigate the overlap between business and IP. Our attorneys can work with you to plan, manage and execute an IP strategy that aligns with your business strategy, to maximise its effectiveness and to protect your commercial interests and investments. We can support you in designing patent and invention processes, such as invention harvesting and decision-making structures, and with internal training and roll-out.

 

Patents - the Keltie difference

Patents will help companies to establish a strong competitive position in the marketplace. Keltie attorneys are adept at helping you understand when and how to expolit your intellectual property through patents.

 

Our UK and European patent attorneys specialise in helping you to maximise the impact of your intellectual asset value chain as well as to understand the risks and rewards open to you in your market sector. We want to help you get the most out of your innovation. With a strategically planned portfolio, managed by our expert team of attorneys and paralegals, we can build the strongest position for your intellectual property to amplify its value now, and in the future.

Continue reading about Patent Attorneys
More
T 56/21 – A missed opportunity for providing legal certainty on adapting the description at the EPO

04.11.2024

T 56/21 – A missed opportunity for providing legal certainty on adapting the description at the EPO

It is typically a requirement at the EPO to amend the description for conformity with the allowable claims before grant of a patent; however, there have been a number of diverging decisions on the matter. The latest decision finds that there is no legal basis for enforcing this requirement, which might suggest that it will no longer be necessary to adapt the description. However, there are other decisions which support the requirement to adapt the description. In view of this, and because the Board of Appeal in this case opted not to involve the highest authority at the EPO in order to clarify the situation, it is unclear as to whether or not the requirement to adapt the description will remain.

More
Case Law Review: Board of Appeal Decision T 1741/22

29.04.2025

Case Law Review: Board of Appeal Decision T 1741/22

Patent applications related to data processing often fall foul of the EPO’s exclusions on “mathematical methods”. Applicants in the MedTech space in particular may find it far easier to protect the hardware in their wearable devices and tools than to protect the software that processes and analyses that data. A recent board of appeal decision T 1741/22 seems to contradict the Guidelines for Examination and previous Board of Appeal decisions. This decision may shed some light on how the EPO may approach these data processing applications in future.

More
Selection inventions in life sciences at the EPO

21.08.2024

Selection inventions in life sciences at the EPO

The EPO practice on selection inventions has developed considerably over the past decade. Two recent decisions of the Technical Board of Appeal are particularly instructive for applicants in the life sciences field. The Guidelines for Examination in the EPO (EPC Guidelines) define selection inventions as those that “deal with the selection of individual elements, subsets, or sub-ranges from a more generic disclosure in the prior art”. The Guidelines address the examination of both novelty and inventive step of selection inventions.

Get in touch

Submit

Thank you